AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2014

Dec 3, 2014

30718_dirs_2014-12-03_dd48e3f5-a75b-4993-8bc9-e66266df6480.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2014-11-25

Reporting Person: Gavin Robert M. (Sen. VP Protein Platforms)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$93.32	2021-07-31	Common Stock (10000)		Direct
Stock Option	$93.32	2021-07-31	Common Stock (50000)		Direct

Footnotes

F1: Includes 5,000 restricted stock units that represent a contingent right to receive one share of Bio-Techne Corporation common stock. The restricted stock units vest if certain performance goals are achieved for calendar 2016.

F2: Vests 2,500 on each of 7/31/2015, 7/31/2016, 7/31/2017 and 7/31/2018.

F3: Includes 50,000 common stock options. The options vest if certain performance goals are achieved for calendar 2016.